Literature DB >> 25816740

4q12 translocations with GSX2 expression identify a CD7(+) acute myeloid leukaemia subset.

Danika Di Giacomo1, Roberta La Starza1, Gianluca Barba1, Valentina Pierini1, Carmen Baldazzi2, Clelia T Storlazzi3, Giulia Daniele3, Fabio Forghieri4, Erika Borlenghi5, Nicoletta Testoni2, Cristina Mecucci6.   

Abstract

Entities:  

Keywords:  4q12-translocations; AML-M0; CD7+; GSX2; leukaemia relapse

Mesh：

Substances：

Year:  2015        PMID： 25816740     DOI： 10.1111/bjh.13368

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  3 in total

1.  Myeloid malignancies with translocation t(4;12)(q11-13;p13): molecular landscape, clonal hierarchy and clinical outcomes.

Authors:  Vincent Parinet; Elise Chapiro; Audrey Bidet; Baptiste Gaillard; Odile Maarek; Laurence Simon; Christine Lefebvre; Sabine Defasque; Marie-Joelle Mozziconacci; Anne Quinquenel; Matthieu Decamp; François Lifermann; Nadia Ali-Ammar; Agathe Maillon; Marine Baron; Mélanie Martin; Stéphanie Struski; Dominique Penther; Jean-Baptiste Micol; Nathalie Auger; Chrystèle Bilhou-Nabera; Jean-Alain Martignoles; Sylvie Tondeur; Florence Nguyen-Khac; Pierre Hirsch; Damien Roos-Weil
Journal:  J Cell Mol Med       Date:  2021-09-07       Impact factor: 5.310

2.  t(4;12)(q12;p13) ETV6-rearranged AML without eosinophilia does not involve PDGFRA: relevance for imatinib insensitivity.

Authors:  Sarah B Mueller; Paola Dal Cin; Long P Le; Dora Dias-Santagata; Jochen K Lennerz; A John Iafrate; Hetal Desai Marble; Andrew M Brunner; Matthew J Weinstock; Marlise R Luskin; Daniel J De Angelo; Richard M Stone; Valentina Nardi
Journal:  Blood Adv       Date:  2022-01-08

3.  Acute myeloid leukemia with t(4;12)(q12;p13): an aggressive disease with frequent involvement of PDGFRA and ETV6.

Authors:  Jingyi Li; Jie Xu; Lynne V Abruzzo; Guilin Tang; Shaoying Li; M James You; Gary Lu; Elias J Jabbour; Qi Deng; Carlos E Bueso-Ramos; L Jeffrey Medeiros; C Cameron Yin
Journal:  Oncotarget       Date:  2017-12-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.